INS and alcoholic fatty liver disease: This compound has shown efficacy in insulin sensitization, glucose modulation, and body weight reduction in diet-induced obese mice models of diabetes, as well as in protecting against alcoholic fatty liver disease [55] and gallbladder carcinoma [46] in murine models.